久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

美國(guó)Navigenics 
Navigenics公司是一家私人持有的個(gè)人基因組學(xué)公司，福斯特城，加利福尼亞州，使用基因測(cè)試，以幫助人們確定他們的健康狀況，幾十個(gè)人風(fēng)險(xiǎn)的基礎(chǔ)。

該公司是業(yè)界日益增長(zhǎng)的個(gè)人基因組學(xué)，提供基因掃描和分析，以個(gè)人和各種應(yīng)用醫(yī)師組成部分。一些企業(yè)已被譽(yù)為家譜他們的測(cè)試工具，然而，Navigenics'的重點(diǎn)是潛在的健康，可以從個(gè)人遺傳信息的認(rèn)識(shí)獲得了好處。

由于部分基因檢測(cè)過(guò)程中，DNA分析技術(shù)的采用范圍確定的遺傳標(biāo)記，可以對(duì)疾病易感性的身體百萬(wàn)。在DNA芯片技術(shù)的迅速降低成本，在基因研究的指數(shù)增長(zhǎng)人類基因組計(jì)劃之后，已經(jīng)幫助使這些技術(shù)更加負(fù)擔(dān)得起日常消費(fèi)者。

Navigenics公司于2006年由大衛(wèi)阿古斯，醫(yī)師表示，前列腺癌專家誰(shuí)指使的應(yīng)用蛋白質(zhì)組學(xué)Spielberg家庭為中心Cedars - Sinai醫(yī)療中心在洛杉磯和迪特里希斯蒂芬博士，教授對(duì)人類遺傳學(xué)家在翻譯基因組學(xué)研究所。

該公司于2007年11月正式推出。 4月8日，2008年，Navigenics開(kāi)始銷售其基因檢測(cè)服務(wù)，其中包括國(guó)家的最先進(jìn)的基因分析，評(píng)估對(duì)一些普通的健康狀況，包括阿爾茨海默氏癥，2型糖尿病的各種您的風(fēng)險(xiǎn)，某些癌癥和腹腔疾病。

隨著衛(wèi)生羅盤(pán)推出Navigenics揭開(kāi)了紐約市，該公司主辦的活動(dòng)和講座對(duì)個(gè)人基因組學(xué)和醫(yī)療SoHo區(qū)一個(gè)臨時(shí)展覽空間。[1]新聞產(chǎn)品的推出，有時(shí)第一手賬戶健康指南針用戶報(bào)告了一個(gè)包括洛杉磯時(shí)報(bào)[6]和Wired雜志出版物的數(shù)量。

該公司還推出了在線門(mén)戶讓醫(yī)生進(jìn)入病人的基因組信息的同意。這個(gè)門(mén)戶允許醫(yī)師融入個(gè)性化的健康病人的遺傳信息的計(jì)劃，旨在幫助早期診斷或預(yù)防保健條件。

2009年7月，Navigenics降低了衛(wèi)生羅盤(pán)全面的基因測(cè)試的價(jià)格為999美元。直到2009年8月31日的測(cè)試價(jià)格為499美元 


          
Navigenics, Inc. is a privately held personal genomics company based in Foster City, California, that uses genetic testing to help people determine their individual risk for dozens of health conditions.

The company is part of the growing personal genomics industry, which offers genetic scans and analysis to individuals and physicians for a variety of applications. Some businesses have touted their tests as genealogical tools, however, Navigenics’ focus is on the potential health benefits that can be gained from being aware of personal genetic information.

As part of the genetic testing process, a range of DNA analysis technologies are employed to identify millions of genetic markers which can predispose the body to diseases. The rapid cost reduction in DNA microarray technology and the exponential growth in genetic research following the Human Genome Project have helped make these technologies more affordable to everyday consumers.

Navigenics was co-founded in 2006 by David Agus, M.D., a prostate cancer specialist who directs the Spielberg Family Center for Applied Proteomics at Cedars-Sinai Medical Center in Los Angeles and Dietrich Stephan, Ph.D., a human geneticist on the faculty of the Translational Genomics Research Institute.

The company officially launched in November 2007. On April 8, 2008, Navigenics began selling its genetic testing services, which include state-of-the-art genetic analysis that assesses your risk for a variety of common health conditions, including Alzheimer’s disease, type 2 diabetes, some cancers and celiac disease.

With the launch of Health Compass, Navigenics opened a temporary exhibition space in the SoHo district of New York City, where the company hosted events and lectures about personal genomics and healthcare.[1] News of the product launch and sometimes first-hand accounts of Health Compass users were reported in a number of publications including the Los Angeles Times[6] and Wired Magazine.

The company also launched an online portal allowing doctors to access the genomic information of consenting patients. The portal allows the physician to integrate patients’ genetic information into personalized health plans designed to help diagnose early or prevent a number of health conditions.

In July 2009, Navigenics lowered the price of the Health Compass comprehensive genetic test to $999. Until August 31, 2009 the price of the test was $499 with promotional code COMPASS-LTO-26225 at checkout.